When Checkweighers Fail: Rethinking Leaflet Control in Pharma Packaging
Following the cartoning process, pharmaceutical production lines are typically equipped with high-precision dynamic checkweighers to verify the weight accuracy of the materials loaded in the carton, thereby detecting whether a product leaflet has been omitted. However, in actual production, particularly when handling large-volume glass bottle products, the weight tolerances of the packaging materials and the drug itself often completely mask the minuscule weight of the leaflet. This makes it impossible for the online checkweigher to detect missing or duplicate leaflets accurately.
1. Technical Reasons for Checkweigher Failure
A specific weight variance analysis is as follows:
* The weight of a single product leaflet typically ranges from 1g to 3g.
* For a 100ml or 500ml large-volume glass bottle, the weight tolerance of the bottle itself can reach ±5g to ±10g.
* Furthermore, filling volume variations in liquid preparations contribute an additional weight fluctuation of approximately ±2%.
Overall, the total weight fluctuation range of a finished carton can be as high as ±15g to ±20g. When the product’s inherent weight tolerance significantly exceeds the leaflet’s weight, the online checkweigher loses its ability to effectively screen for errors.
If the rejection threshold is set too strictly (e.g., ±3g), the production line will experience frequent false rejections due to the normal weight fluctuations of the packaging materials, severely impacting production efficiency. Conversely, if the threshold is set too loosely (e.g., ±20g), defective products missing a leaflet will escape detection and flow into the market. Therefore, in this specific scenario, online checkweighing fails to provide substantial quality assurance.
2. Strategy Shift: From “End-of-Line Guesswork” to “Process Control”
Given the failure of physical measurement methods, the control strategy should revert to the fundamental management requirement of a “100% leaflet material balance rate”. Compared with relying on weight-based guesswork at the end of the line, shifting control upstream and implementing precise counting during production is far more scientific and reliable.
During production, the cartoning machine folds the leaflet and inserts it into the carton. If the equipment features a counting function synchronized with the folding action, the exact consumption of leaflets can be accurately captured. Upon completion of batch production, by tallying the number of finished cartons and accounting for discarded and remaining leaflets, the 100% material balance rate can be verified, thereby confirming that neither duplicate nor missing leaflets occurred during the batch production. The objectively recorded number of folds by the equipment serves as conclusive data, completely unaffected by fluctuations in bottle weight or filling volume.
3. Addressing Extreme Cases and Residual Risk Management
Theoretically, there is an extremely low-probability extreme case: one carton receives an extra leaflet while another is missing one, yet the overall material balance still presents a perfect 100% state.
However, the core of quality management lies in controlling risks to an acceptable level rather than pursuing an absolute “zero incidence rate”. Management decisions aim to minimize the probability of adverse events, but in real-world industrial manufacturing, achieving an absolute 100.0% defect-free reality is impossible.
To address this extremely low-probability residual risk, effective compensatory measures can be implemented: adding a barcode or QR code to the exterior of the packaging carton. In the rare event of a missing leaflet, patients can scan the packaging to access an electronic version, effectively bridging the information gap.
4. Practical Recommendations for Quality Management
Based on the above analysis, the following four practical recommendations are proposed to address this production pain point:
* First, redefine the problem. The core issue is not “how to detect a leaflet using a checkweigher” but rather “how to ensure that each carton contains exactly one leaflet. Accurately defining the problem is a prerequisite for developing an effective solution.
* Second, optimize the control strategy. When a single physical measurement method fails, its limitations must be acknowledged, and the control focus should pivot to process control (i.e., “equipment fold counting combined with strict material balance”). This aligns closely with the GMP management concepts of “risk-based” and “process control” paradigms.
* Third, strengthen data support. Utilize historical customer complaint records and equipment operation logs to demonstrate equipment stability and the extremely low probability of deviations with solid data. Formally evaluate this risk during the Annual Product Quality Review (PQR) to confirm that it is controllable, thereby avoiding unnecessary investments in redundant equipment.
* Fourth, perfect contingency plans. To manage residual risks that cannot be entirely eliminated, companies should establish comprehensive emergency and remedial plans, including an efficient complaint-handling process, a reasonable compensation mechanism, and supplementary services like electronic leaflets, to ensure patient rights are adequately protected in the event of occasional deviations.
Conclusion
Quality management should avoid falling into dogmatism or unthinkingly pursuing an absolute “zero risk”. Accurately identifying the essence of a risk and adopting economical, reliable control methods that closely align with the realities of the manufacturing process is the scientific path to achieving high-quality pharmaceutical production.
The views expressed in this article represent a personal practical approach within a specific process scenario. Because production conditions and risk tolerance levels vary among companies, specific solutions should be evaluated based on actual circumstances. We welcome any corrections or discussions on areas that may be lacking.